Funder: Wellcome Foundation
Due Dates: June 2, 2026 (Full application, 15:00 BST)
Funding Amounts: £1,000,000–£8,000,000 per award | 3–5 years duration | 8–12 awards expected
Summary: Supports transdisciplinary teams led from Africa, South Asia, or South-East Asia to run clinical trials optimising licensed pharmaceutical interventions for infectious diseases, aiming to inform policy and improve health outcomes in low- and middle-income countries.
Key Information: Lead applicant and at least one coapplicant must be based in eligible regions; research must focus on specified infectious diseases.